Results 201 to 210 of about 7,668 (229)

Plasticity of polypoidal lesions in polypoidal choroidal vasculopathy

Graefe's Archive for Clinical and Experimental Ophthalmology, 2004
The aim of this study was to describe the clinical course in a patient with polypoidal choroidal vasculopathy (PCV).A 68-year-old man with PCV in the left eye was followed up by means of routine examinations including fluorescein angiography and indocyanine green angiography for over 60 months.Throughout the follow-up period, the patient experienced ...
Akiko, Okubo, Munefumi, Sameshima, Taiji, Sakamoto   +2 more
openaire   +2 more sources

Polypoidal Choroidal Vasculopathy

2016
Polypoidal choroidal vasculopathy (PCV) is a disease reported by Yannuzzi et al. (1990) in 1990 and is now considered one of phenotypes of age-related macular degeneration (AMD). While exudative AMD is seen in approximately 5–10 % of western populations, various previous reports have confirmed that its prevalence is high in Asian countries including ...
Ichiro Maruko, Tomohiro Iida
  +4 more sources

Polypoidal Choroidal Vasculopathy

Klinische Monatsblatter fur Augenheilkunde, 2013
Polypoidal choroidal vasculopathy (PCV) is a disease that was first described almost 30 years ago. The disease is characterised by alterations of the posterior pole such as serous or serosanguineous detachments of the retina or the retinal pigment epithelium (RPE) around the optic nerve or in the central macula.
Tarun Sharma, Muna Bhende, Pukhraj Rishi, Ekta Rishi   +3 more
  +5 more sources

Multimodal imaging comparison of polypoidal choroidal vasculopathy between Asian and Caucasian population.

American journal of ophthalmology-glaucoma, 2021
PURPOSE Differences in multimodal imaging features between Asians and Caucasians eyes may contribute to our understanding of the etiology of the polypoidal choroidal vasculopathy (PCV).
F. Corvi, S. Chandra, A. Invernizzi, Lucia Pace, F. Viola, S. Sivaprasad, G. Staurenghi, C. Cheung, K. Teo   +8 more
semanticscholar   +1 more source

DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.

Retina, 2020
PURPOSE Recent investigations have found a biphasic pattern of choroidal thickness within polypoidal choroidal vasculopathy (PCV) patients. This study aims to investigate the relationship between choroidal thickness and the clinical features of PCV eyes.
Yun-Chia Chang, Cheng-Kuo Cheng
semanticscholar   +1 more source

Comparison of one-year outcomes between as-needed brolucizumab and aflibercept for polypoidal choroidal vasculopathy

Japanese Journal of Ophthalmology, 2023
Y. Fukuda, Yoichi Sakurada, Mio Matsubara, Yumi Kotoda, Yuka Kasai, A. Sugiyama, K. Kashiwagi   +6 more
semanticscholar   +1 more source

Brolucizumab in polypoidal choroidal vasculopathy

Expert Opinion on Biological Therapy, 2022
Ashish Sharma, Nikulaa Parachuri, Nilesh Kumar, Baruch D Kuppermann, Anat Loewenstein, Francesco Bandello   +5 more
openaire   +3 more sources

Switching to brolucizumab from aflibercept in age-related macular degeneration with type 1 macular neovascularization and polypoidal choroidal vasculopathy: an 18-month follow-up study

Graefe's Archive for Clinical and Experimental Ophthalmology, 2022
Tomoko Ueda-Consolvo, Aya Tanigichi, Ayaka Numata, Toshihiko Oiwake, Tomoko Nakamura, Masaaki Ishida, S. Yanagisawa, A. Hayashi   +7 more
semanticscholar   +1 more source

Progression of Polypoidal Lesions Associated with Exudative Recurrence in Polypoidal Choroidal Vasculopathy

Ophthalmology, 2023
Quan Yan, Qiyu Bo, Jieqiong Chen
exaly  

Emerging Importance of Polypoidal Choroidal Vasculopathy.

Ophthalmology Retina
G. Kokame
semanticscholar   +1 more source